GT Biopharma, Inc. (GTBP)
0.6725
+0.03
(+5.08%)
USD |
NASDAQ |
Dec 10, 16:00
0.67
0.00 (0.00%)
After-Hours: 20:00
GT Biopharma Market Cap: 7.153M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Plus Therapeutics, Inc. | 92.38M |
| Geron Corp. | 817.09M |
| Regeneron Pharmaceuticals, Inc. | 76.32B |
| SELLAS Life Sciences Group, Inc. | 279.19M |
| Xencor, Inc. | 1.225B |
Market Cap Related Metrics
| Price to Book Value | 2.385 |
| Price | 0.6725 |
| Earnings Yield | -504.8% |